4//SEC Filing
Adverum Biotechnologies, Inc. 4
Accession 0001209191-17-010103
CIK 0001501756operating
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 5:35 PM ET
Size
12.7 KB
Accession
0001209191-17-010103
Insider Transaction Report
Form 4
Barone Samuel B.
Chief Medical Officer
Transactions
- Award
Common Stock
2017-02-09+58,000→ 172,335 total - Award
Stock Option (Right to Buy)
2017-02-09+84,000→ 84,000 totalExercise: $2.70Exp: 2027-02-08→ Common Stock (84,000 underlying)
Footnotes (2)
- [F1]Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of Common Stock of the Issuer for each one (1) RSU upon the vesting thereof. Such RSUs vest with respect to 25% of the shares subject thereto on each anniversary of February 9, 2017 (the "Vesting Commencement Date"), such that all of the shares subject to the RSUs shall be vested as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each such vesting date.
- [F2]Twenty-five percent (25%) of the total number of shares subject to the option vest and become exercisable on the first anniversary of the Vesting Commencement Date, and 1/48th of the total number of shares subject to the option vest and become exercisable each month thereafter, such that all of the shares subject to the option shall become vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each such vesting date.
Issuer
Adverum Biotechnologies, Inc.
CIK 0001501756
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001501756
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 5:35 PM ET
- Size
- 12.7 KB